LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Lexaria Bioscience Corp.
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026
$2.60−0.26 (-9.09%)
Close on Oct 19, 2026
- Market cap
- $64.50M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Lexaria Bioscience's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Richard Christopher | Chief Executive Officer, Director | 65,000 | 0.26% | Jul 30, 2025 |
| John Martin Docherty | President & CSO, Director | 59,451 | 0.24% | Jul 30, 2025 |
| Vanessa Carle | Secretary | 750 | 0.00% | Jul 30, 2025 |
| Michael Elliot Shankman | Chief Financial Officer | – | – | May 16, 2025 |
| Christopher Bunka | Director | 555,455 | 2.24% | Mar 18, 2026 |
| William Edward McKechnie | Director | 18,191 | 0.07% | Jul 30, 2025 |
| Albert L. Reese Jr | Director | 10,917 | 0.04% | May 16, 2025 |
| Nicholas W. Baxter | Director | 11,000 | 0.04% | May 16, 2025 |
| Baljinder Bhullar | Director | 13,000 | 0.05% | May 16, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Christopher Bunka Director | Mar 17, 2026 | Gift | −100,000 | – | – | 273,543 |
| Christopher Bunka Director | Jul 30, 2025 | Buy | +11,900 | $0.91 | $10.83K | 281,912 |
| Vanessa Carle Secretary | Jul 29, 2025 | Buy | +750 | $0.91 | $683 | 750 |
| Richard Christopher Chief Executive Officer, Director | Jul 29, 2025 | Buy | +15,000 | $0.91 | $13.65K | 65,000 |
| William Edward McKechnie Director | Jul 29, 2025 | Buy | +5,000 | $0.91 | $4.55K | 18,191 |
| John Martin Docherty President & CSO, Director | Jul 29, 2025 | Buy | +5,376 | $0.93 | $5.00K | 5,376 |
| Christopher Bunka Director | Jul 29, 2025 | Buy | +15,600 | $0.92 | $14.35K | 270,012 |
| Christopher Bunka Director | Jan 7, 2025 | Award | +100,000 | – | – | 373,543 |
| Richard Christopher Chief Executive Officer | Dec 3, 2024 | Buy | +27,172 | $2.47 | $67.11K | 50,000 |
| Richard Christopher Chief Executive Officer | Dec 2, 2024 | Buy | +22,828 | $2.24 | $51.13K | 22,828 |
| Catherine C. Turkel Director | Aug 12, 2024 | Buy | +1,600 | $3.13 | $5.01K | 3,100 |
| Vanessa Carle Secretary | Jul 31, 2024 | Sale | −2,567 | $4.00 | $10.27K | 0 |
| Vanessa Carle Secretary | May 14, 2024 | Option exercise | +2,500 | $1.15 | $2.88K | 2,567 |
| Catherine C. Turkel Director | Feb 9, 2023 | Buy | +1,500 | $2.84 | $4.26K | 1,500 |
| Gregory Downey Chief Financial Officer | Oct 14, 2022 | Buy | +121 | $2.09 | $253 | 1,954 |
| Gregory Downey Chief Financial Officer | Oct 14, 2022 | Award | +121 | $2.09 | $253 | 1,954 |
| Christopher Bunka Chief Executive Officer, Director | Oct 13, 2022 | Buy | +16,600 | $2.10 | $34.86K | 254,412 |
| Christopher Bunka CEO, Director | Oct 13, 2022 | Award | +16,600 | $2.10 | $34.86K | 254,412 |
| Christopher Bunka Chief Executive Officer, Director | Oct 12, 2022 | Buy | +21,900 | $1.99 | $43.58K | 237,812 |
| Christopher Bunka CEO, Director | Oct 12, 2022 | Award | +21,900 | $1.99 | $43.58K | 237,812 |
| Albert L. Reese Jr Director | May 24, 2022 | Award | +5,000 | $1.96 | $9.80K | 10,917 |
| Albert L. Reese Jr Director | May 20, 2022 | Award | +1,799 | $2.01 | $3.62K | 5,917 |
| Albert L. Reese Jr Director | May 19, 2022 | Award | +1,501 | $2.01 | $3.02K | 4,118 |
| Albert L. Reese Jr Director | May 18, 2022 | Award | +1,700 | $2.01 | $3.42K | 2,617 |
| Christopher Bunka CEO, Director, 10% owner | Nov 10, 2020 | Buy | +10,000 | $0.20 | $2.00K | 6,445,844 |
| Christopher Bunka CEO, Director, 10% owner | Nov 10, 2020 | Buy | +25,500 | $0.19 | $4.85K | 6,477,344 |
| Christopher Bunka CEO, Director, 10% owner | Nov 10, 2020 | Buy | +6,000 | $0.20 | $1.20K | 6,451,844 |
| Christopher Bunka CEO, Director, 10% owner | Nov 9, 2020 | Buy | +6,500 | $0.20 | $1.30K | 6,413,844 |
| Christopher Bunka CEO, Director, 10% owner | Nov 9, 2020 | Buy | +22,000 | $0.20 | $4.40K | 6,435,844 |
| Christopher Bunka CEO, Director, 10% owner | Nov 9, 2020 | Buy | +37,500 | $0.22 | $8.25K | 6,379,344 |
| Christopher Bunka CEO, Director, 10% owner | Nov 9, 2020 | Buy | +10,000 | $0.20 | $2.00K | 6,389,344 |
| Christopher Bunka CEO, Director, 10% owner | Nov 9, 2020 | Buy | +10,000 | $0.21 | $2.10K | 6,399,344 |
| Christopher Bunka CEO, Director, 10% owner | Nov 9, 2020 | Buy | +8,000 | $0.20 | $1.60K | 6,407,344 |
| Christopher Bunka CEO, Director, 10% owner | Nov 6, 2020 | Buy | +60,000 | $0.21 | $12.60K | 6,341,844 |
| William Edward McKechnie Director | Jul 23, 2020 | Option exercise | +110,000 | $0.17 | $18.70K | 395,738 |
| Christopher Bunka CEO, Director, 10% owner | May 6, 2020 | Award | +200,000 | $0.23 | $46.00K | 6,281,844 |
| Nicholas W. Baxter Director | Dec 20, 2019 | Option exercise | +110,000 | $0.10 | $11.00K | 330,000 |
| Allan Horst Spissinger Chief Financial Officer | Feb 15, 2019 | Option exercise | +50,000 | $0.37 | $18.50K | 119,116 |
| John Martin Docherty President, Director | Aug 31, 2018 | Award | +36,500 | $2.07 | $75.56K | 1,622,250 |
| Christopher Bunka CEO, Director, 10% owner | Aug 31, 2018 | Award | +32,500 | $2.07 | $67.28K | 7,126,304 |
| Christopher Bunka CEO, Director, 10% owner | Aug 14, 2018 | Gift | −500,000 | – | – | 7,093,804 |
| Christopher Bunka CEO, Director, 10% owner | Aug 3, 2018 | Award | +81,250 | $1.24 | $100.75K | 7,593,804 |
| John Martin Docherty Director, 10% owner | Aug 3, 2018 | Award | +182,500 | $1.32 | $240.90K | 1,494,500 |
| John Martin Docherty Director, 10% owner | Aug 3, 2018 | Award | +91,250 | $1.24 | $113.15K | 1,585,750 |
| Christopher Bunka CEO, Director, 10% owner | Jun 18, 2018 | Option exercise | +247,500 | $0.09 | $22.28K | 7,512,554 |
| Christopher Bunka CEO, Director, 10% owner | Jun 18, 2018 | Option exercise | +450,000 | $0.14 | $63.00K | 6,081,844 |
| William Edward McKechnie Director | May 31, 2018 | Sale | −2,100 | $1.90 | $3.99K | 285,738 |
| William Edward McKechnie Director | May 30, 2018 | Sale | −47,800 | $1.90 | $90.82K | 287,938 |
| William Edward McKechnie Director | May 30, 2018 | Sale | −100 | $1.91 | $191 | 287,838 |
| Christopher Bunka CEO, Director, 10% owner | Dec 1, 2017 | Award | +29,475 | $0.82 | $24.17K | 7,265,054 |
| Allan Horst Spissinger CFO | Dec 1, 2017 | Award | +41,666 | $0.82 | $34.17K | 69,166 |
| William Edward McKechnie Director | Dec 1, 2017 | Award | +14,634 | $0.82 | $12.00K | 335,738 |
| John Martin Docherty Director, 10% owner | Dec 1, 2017 | Award | +35,000 | $0.82 | $28.70K | 1,312,000 |
| William Edward McKechnie Director | Aug 28, 2017 | Award | +32,433 | $0.37 | $12.00K | 321,104 |
| John Martin Docherty President, Director | Jun 22, 2017 | Award | +210,000 | $0.30 | $63.00K | 1,277,000 |
| Christopher Bunka CEO, Director, 10% owner | Jun 21, 2017 | Award | +210,000 | $0.30 | $63.00K | 5,631,844 |
| William Edward McKechnie Director | May 31, 2017 | Award | +35,294 | $0.34 | $12.00K | 288,671 |
| William Edward McKechnie Director | May 31, 2017 | Award | +35,249 | $0.34 | $11.98K | 288,626 |
| William Edward McKechnie Director | Feb 22, 2017 | Award | +29,091 | $0.55 | $16.00K | 253,377 |
| William Edward McKechnie Director | Oct 11, 2016 | Award | +114,286 | $0.14 | $16.00K | 224,286 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.